Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Jean-Francois Gélinas, who has secured an EIT Health Transition Fellowship.

Two researchers at benches © Academy of Medical Sciences

The scheme focuses on providing funding to close the gap between completion of a doctoral thesis and obtaining seed funding for innovative idea based on DPhil research. Jean-Francois, a DPhil student with Prof Deborah Gill and Prof Steve Hyde, has secured a Gold Award worth €27,500 to further his research on enhancing lentiviral vector production for gene therapy. He has also been invited to Barcelona to pitch his innovation to EIT Health partners. Well done Jean-Francois!

See the EIT Health Transition Fellowship.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.